caffeic acid phenethyl ester has been researched along with juglone in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (juglone) | Trials (juglone) | Recent Studies (post-2010) (juglone) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 359 | 0 | 212 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | juglone (IC50) |
|---|---|---|---|
| 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ | Yersinia pseudotuberculosis YPIII | 5.35 | |
| Aurora kinase A | Homo sapiens (human) | 0.05 | |
| DNA topoisomerase 1 | Homo sapiens (human) | 8.26 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 1 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3.035 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 1.98 | |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 5.9 | |
| Aurora kinase B | Homo sapiens (human) | 0.62 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arasoglu, T; Ates, SC; Derman, S; Durak, S | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and juglone
| Article | Year |
|---|---|
Enhanced antibacterial and antiparasitic activity of multifunctional polymeric nanoparticles.
Topics: Anti-Bacterial Agents; Antiparasitic Agents; Caffeic Acids; Escherichia coli; Leishmania; Microbial Sensitivity Tests; Nanoparticles; Naphthoquinones; Particle Size; Phenylethyl Alcohol; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus | 2020 |